Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Ridgepost Capital Rpc Stock Good For Portfolio Price At 6.99 Down 1.41 20260410 Is 1St Source Srce Stock Cheap At Current Price Price At 72.89 Up 1.41 20260408 Is Jinxin Nami Stock Breaking Resistance Price At 0.52 Down 9.55 20260406 How Expensive Is Silgan Holdings Slgn Stock Now Price At 39.38 Down 0.18 20260407 Cisco Systems Inc CSCO Strategic Positioning in AI Infrastructure BuildOut What PPlus Tr PYT is doing that smart investors recognize Underperforming 20260507 RDNW RideNow Group Inc posts small Q4 2025 pershare loss miss while shares rise modestly in recent trading Greenland GTEC Future Outlook Q4 2025 EPS Misses Views Quantum Computing Stocks Surge on US Governments 2 Billion Funding Plan and Equity Stakes Federal Reserve Dissenters Explain Opposition to Signal of Rate Cuts Kashkari Logan Hammack Cite Economic Uncertainty Home Equity Loan and HELOC Rates Hit Yearly Lows as Closing Times Vary Significantly Wholesale Inflation Surges 6 YearoverYear in April Marking Sharpest Rise Since 2022 Fed Rate Cut Prospects Fade as Jobs Report Highlights Persistent Cost Pressures Kevin Warsh Set to Be Sworn In as Federal Reserve Chair This Friday GRRR Q4 2025 Earnings Significant EPS Miss Amidst Unclear Revenue Outlook SUNE Q2 2024 Earnings Massive EPS Beat Signals Cost Discipline but Revenue Remains Undisclosed HLIT Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiencies Gaming and Leisure Properties Inc GLPI Q1 2026 Earnings EPS Misses Estimates Stock Sees Modest Uptick EH Q4 2025 Earnings Massive EPS Surprise as Profitability Arrives Knowles Corporation KN Q1 2026 Earnings EPS Beat Drives Stock Higher Iovance Biotherapeutics IOVA Hovers Near Key Support as Stock Edges Lower FCPT Stock Slips 05 as Investors Gauge Real Estate Sector Stability Ameresco AMRC Surges 6 as Clean Energy Momentum Builds Astrotech Corporation ASTC Surges Over 450 in Historic Rally on Key Corporate Development ProQR Therapeutics PRQR Edges Higher as Shares Approach Key Resistance Levels